-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Tag Archives: eye infections
FDA Warning Brilliant Blue G
Translation Certain Compounded Drugs from Franck’s: FDA Issues Second Warning to Physicians Brilliant Blue G (BBG) Triamcinolone AUDIENCE: Eye Care, Family Practice, Pharmacy ISSUE: FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant … Continue reading
Posted in Eye Care, Family Practice, FDA 2012, FDA Warning, Pharmacy
Tagged Brilliant Blue G, Eye Care, eye infections, Family Practice, FDA warning, fungal endophthalmitis, Pharmacy, Triamcinolone
Comments Off
Brilliant Blue G Recall
TranslationBrilliant Blue G: Recall of Unapproved Drug – Ongoing Investigation of Fungal Endophthalmitis Cases AUDIENCE: Ophthalmology, Risk Manager ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. Clinicians … Continue reading
Posted in FDA 2012, FDA Recall, Ophthalmology, Risk Manager
Tagged Brilliant Blue G Recall, drug risks, eye infections, eye surgery, FDA recall, Franck’s Compounding Lab, fungal endophthalmitis, Fungal Endophthalmitis Cases, Ocala Florida, Ongoing Investigation, Ophthalmology, Recall, Unapproved Drug
Comments Off